ProfileGDS4459 / ENSG00000131650
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 73% 77% 69% 79% 68% 72% 74% 70% 68% 75% 70% 65% 73% 60% 66% 74% 77% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.4473
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 25.6277
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.3369
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.7679
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.268
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.4372
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.7474
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.3470
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.2568
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.7775
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.2570
GSM623475group B, liver allograft wedge biopsie placebo treatment 25.1265
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.5173
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.7560
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.1466
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.474
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.7177